Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-26 ARMISTICE CAPITAL, LLC Director Sale −0 5,440,000
2020-06-26 ARMISTICE CAPITAL, LLC Director Option exercise · Warrants −16,666,667 0
2020-06-26 ARMISTICE CAPITAL, LLC Director Option exercise · Warrants −0 0
2020-06-15 Floroiu Cezar Andrei Chief Executive Officer Grant or award · Stock Option (right to buy) +845,280 845,280
2020-06-15 Floroiu Cezar Andrei Chief Executive Officer Grant or award · Stock Option (right to buy) +900,000 900,000
2020-06-08 Yedid Robert A. Director Grant or award · Stock Option (right to buy) +65,700 65,700
2020-06-08 Finney Michael J. Director Grant or award · Stock Option (right to buy) +65,700 65,700
2020-06-08 Davis Todd C Director Grant or award · Stock Option (right to buy) +65,700 65,700
2020-06-08 Floroiu Cezar Andrei Director Grant or award · Stock Option (right to buy) +54,720 54,720
2020-06-08 Echerd Margaret VP, Corporate Controller, PAO Grant or award · Stock Option (right to buy) +315,000 315,000
2020-06-08 Tucker Sean Chief Scientific Officer Grant or award · Stock Option (right to buy) +360,000 360,000
2020-06-08 Latour Wouter President and Chief Executive Grant or award · Stock Option (right to buy) +900,000 900,000
2020-06-03 ARMISTICE CAPITAL, LLC Director Sale −400,000 $2.77 $1.1M 7,000,000
2020-06-03 ARMISTICE CAPITAL, LLC Director Sale −0 7,000,000
2020-06-02 ARMISTICE CAPITAL, LLC Director Sale −800,000 $2.75 $2.2M 7,400,000
2020-06-02 ARMISTICE CAPITAL, LLC Director Sale −0 7,400,000
2020-06-01 ARMISTICE CAPITAL, LLC Director Sale −200,000 $2.74 $548K 8,200,000
2020-06-01 ARMISTICE CAPITAL, LLC Director Sale −0 8,200,000
2020-05-27 ARMISTICE CAPITAL, LLC Director Sale −200,000 $2.61 $522K 8,400,000
2020-05-27 ARMISTICE CAPITAL, LLC Director Sale −0 8,400,000

Page 15 of 23 · 442 trades